Filter
131
Text search:
Novartis
Featured
Recommendations
11
New Publications
25
Language
Document type
No document type
66
Studies & Reports
38
Guidelines
14
Strategic & Response Plan
7
Situation Updates
2
Fact sheets
2
Manuals
1
Resource Platforms
1
Countries / Regions
Global
9
Africa
6
Tanzania
5
South Africa
5
India
4
Indonesia
3
Russia
3
Ghana
2
Philippines
2
Germany
2
Cambodia
2
Ukraine
2
Latin America and the Carribbean
2
Western and Central Europe
2
Sierra Leone
1
Nigeria
1
Ethiopia
1
Nepal
1
Kenya
1
Bangladesh
1
Malawi
1
Mozambique
1
Namibia
1
Brazil
1
Chile
1
Asia
1
Venezuela
1
Authors & Publishers
Publication Years
Category
Countries
34
Public Health
16
Clinical Guidelines
9
Pharmacy & Technologies
7
Women & Child Health
1
Key Resources
1
Toolboxes
Mental Health
27
NCDs
23
NTDs
17
COVID-19
7
AMR
5
Pharmacy
5
Disability
4
TB
4
Planetary Health
4
Global Health Education
3
Ebola
2
Rapid Response
2
Caregiver
2
Refugee
1
HIV
1
Guidelines for Primary, Secondary and Tertiary Level Care
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background,
...
В настоящем отчете (это уже четвертое его издание) анализируются препятствия и факторы, затрудняющие доступ к препаратам для лечения лекарственно-устойчивого туб
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
WHO promotes the inclusion of foodborne trematodiases among the targets of preventive chemotherapy interventions. With the aim of providing access to quality medicines, WHO has negotiated with Novartis Pharma AG whereby
...
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
The 2018 Access to Medicine Index finds that the pharmaceutical industry continues to mature in its approach to access to medicine, with models for good practice in areas such as access planning and licensing. GSK retains its No. 1 position, as Novartis
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
Introduction
Chapter A.9
Introdução
Capítulo A.9
Edição em Português
Editor: Flávio Dias Silva.
Tradutores: Letícia Tomaz Oliveira, Luciano da Silva Quadros
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand
...
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
Ein Dossier der VENRO-AG Gesundheit in Zusammenarbeit mit der Redaktion Welt-sichten
Epilepsia, 55(4):475–482, 2014
doi: 10.1111/epi.12550
DOI:https://doi.org/10.1016/S2213-2600(20)30316-7
The Lancet Respiratory Medicine
Report of the Review Committee on the Functioning of the International Health Regulations (2005) in relation to Pandemic (H1N1) 2009
